Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,132 | -61,368 | -52,028 | -57,878 | -74,286 |
| Depreciation Amortization | 78 | -409 | 434 | 1,249 | 1,313 |
| Accounts payable and accrued liabilities | 2,630 | 432 | 448 | -4,625 | 4,914 |
| Other Working Capital | 226 | 593 | -99 | -5,496 | 6,729 |
| Other Operating Activity | -2,501 | 9,265 | 7,461 | 14,775 | 1,776 |
| Operating Cash Flow | $-22,699 | $-51,487 | $-43,784 | $-51,975 | $-59,554 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -6,759 | 35,702 | 52,072 | -91,504 |
| PPE Investments | -83 | -108 | -55 | -660 | -595 |
| Other Investing Activity | 0 | 0 | 0 | 35 | -19 |
| Investing Cash Flow | $-83 | $-6,867 | $35,647 | $51,447 | $-92,118 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 20,000 | N/A | N/A |
| Common Stock Issued | N/A | 67,220 | 195 | 220 | 131,018 |
| Common Stock Repurchased | N/A | -312 | N/A | N/A | -473 |
| Other Financing Activity | 19,395 | 0 | -3,633 | -2,935 | -1,381 |
| Financing Cash Flow | $19,395 | $66,908 | $16,562 | $-2,715 | $129,164 |
| Beginning Cash Position | 4,396 | 40,777 | 32,352 | 35,595 | 58,103 |
| End Cash Position | 1,009 | 49,331 | 40,777 | 32,352 | 35,595 |
| Net Cash Flow | $-3,387 | $8,554 | $8,425 | $-3,243 | $-22,508 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,699 | -51,487 | -43,784 | -51,975 | -59,554 |
| Capital Expenditure | -83 | -108 | -55 | -660 | -595 |
| Free Cash Flow | -22,782 | -51,595 | -43,839 | -52,635 | -60,149 |